This second episode in our series on consolidation in healthcare centers around the Federal Trade Commission’s role (FTC) of enforcing the nation’s antitrust laws and ensuring competition within the industry. Special guest Mark D. Seidman, Assistant Director for the Mergers IV Division at the FTC, explains how the agency investigates mergers and their impact on the future of healthcare delivery.
Douglas Lundy, MD, MBA, FAAOS, AAOS Advocacy Council Chair
Mark D. Seidman, Assistant Director for the Mergers IV Division at the Federal Trade Commission
More From The Bone Beat
Listen to more episodes and be sure to subscribe to receive updates when new episodes are released on the last Tuesday of each month. If you enjoy the content and find the conversations valuable, please rate the show or leave a review.